JP2010273685A5 - - Google Patents

Download PDF

Info

Publication number
JP2010273685A5
JP2010273685A5 JP2010166570A JP2010166570A JP2010273685A5 JP 2010273685 A5 JP2010273685 A5 JP 2010273685A5 JP 2010166570 A JP2010166570 A JP 2010166570A JP 2010166570 A JP2010166570 A JP 2010166570A JP 2010273685 A5 JP2010273685 A5 JP 2010273685A5
Authority
JP
Japan
Prior art keywords
protein
antibody
seq
vertebrate
purified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010166570A
Other languages
English (en)
Other versions
JP2010273685A (ja
Filing date
Publication date
Priority claimed from US08/400,159 external-priority patent/US5869282A/en
Application filed filed Critical
Publication of JP2010273685A publication Critical patent/JP2010273685A/ja
Publication of JP2010273685A5 publication Critical patent/JP2010273685A5/ja
Withdrawn legal-status Critical Current

Links

Claims (23)

  1. 配列番号2、配列番号6、配列番号14及び配列番号16から成る群より選択されるアミノ酸配列を含む、精製された脊椎動物のSerrateタンパク質。
  2. 哺乳動物のタンパク質である、請求項1に記載の精製された脊椎動物のSerrateタンパク質。
  3. ヒトのタンパク質である、請求項1に記載の精製された脊椎動物のSerrateタンパク質。
  4. 前記ヒトのタンパク質が配列番号2を含む、請求項3に記載の精製された脊椎動物のSerrateタンパク質。
  5. 配列番号4を含む、精製されたヒトSerrateタンパク質。
  6. 脊椎動物のSerrateタンパク質ではない第2のタンパク質のアミノ酸配列に共有結合を介して融合された、請求項1〜5のいずれか1項に記載のタンパク質を含む精製されたキメラタンパク質。
  7. 請求項1〜5のいずれか1項に記載の脊椎動物のSerrateタンパク質又は請求項6に記載のキメラタンパク質をコードする、単離された核酸。
  8. 配列番号1、配列番号5、配列番号13および配列番号15からなる群より選択されるヌクレオチド配列を含む、単離された核酸。
  9. 配列番号3を含む、単離された核酸。
  10. 請求項7〜9のいずれか1項に記載の核酸を含む核酸ベクター。
  11. 請求項10に記載の核酸ベクターにより形質転換された組換え細胞。
  12. 請求項1〜5のいずれか1項に記載の脊椎動物のSerrateタンパク質又は請求項6に記載のキメラタンパク質の生産方法であって、前記タンパク質又はキメラタンパク質が請求項11に記載の組換え細胞によって発現されるように、前記細胞を増殖させること、及び発現した前記タンパク質又はキメラタンパク質を回収することを含む、方法。
  13. 請求項1〜4のいずれか1項に記載の脊椎動物のSerrateタンパク質と結合する、精製された抗体。
  14. 請求項5に記載のヒトSerrateタンパク質と結合する、精製された抗体。
  15. モノクローナル抗体である、請求項13または14に記載の抗体。
  16. ポリクローナル抗体である、請求項13または14に記載の抗体。
  17. 請求項1〜5のいずれか1項に記載のタンパク質を用いて宿主動物を免疫すること、及び前記タンパク質と結合する抗体を選択することを含む、請求項13または14に記載の抗体の生産方法。
  18. ショウジョウバエ(Drosophila)のSerrateタンパク質とは結合しない、請求項13〜16のいずれか1項に記載の抗体。
  19. 請求項1〜5のいずれか1項に記載の脊椎動物のSerrateタンパク質の誘導体であって、前記脊椎動物のSerrateタンパク質のアミノ酸配列内において、1以上のアミノ酸残基がサイレントな変化を生じる機能的等価物として作用する類似の極性を有する別のアミノ酸によって置換されているアミノ酸配列を有し、且つ脊椎動物のSerrateタンパク質に対する抗体と特異的に結合する、誘導体。
  20. 請求項4に記載のヒトのSerrateタンパク質と結合する、請求項13に記載の抗体。
  21. ショウジョウバエ(Drosophila)のSerrateタンパク質とは結合しない、請求項20に記載の抗体。
  22. 請求項1に記載の脊椎動物のSerrateタンパク質または請求項5に記載のヒトSerrateタンパク質をコードするRNA転写産物の少なくとも15ヌクレオチド部分に絶対的に相補的な配列を含み、且つ前記RNA転写産物にハイブリダイズする、少なくとも15ヌクレオチドを含む単離されたオリゴヌクレオチド。
  23. 細胞において、請求項1〜5のいずれか1項に記載の脊椎動物のSerrateタンパク質をコードする核酸の発現を抑制する方法であって、前記核酸の発現を抑制するのに有効な量の請求項22に記載のオリゴヌクレオチドをin vitroで前記細胞に供給することを含む、方法。
JP2010166570A 1995-03-07 2010-07-23 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法 Withdrawn JP2010273685A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/400,159 US5869282A (en) 1991-12-11 1995-03-07 Nucleotide and protein sequences of the serrate gene and methods based thereon

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2007260391A Division JP2008099687A (ja) 1995-03-07 2007-10-03 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013023179A Division JP2013150605A (ja) 1995-03-07 2013-02-08 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法

Publications (2)

Publication Number Publication Date
JP2010273685A JP2010273685A (ja) 2010-12-09
JP2010273685A5 true JP2010273685A5 (ja) 2011-07-14

Family

ID=23582455

Family Applications (4)

Application Number Title Priority Date Filing Date
JP8527061A Withdrawn JPH11507203A (ja) 1995-03-07 1996-03-07 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法
JP2007260391A Withdrawn JP2008099687A (ja) 1995-03-07 2007-10-03 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法
JP2010166570A Withdrawn JP2010273685A (ja) 1995-03-07 2010-07-23 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法
JP2013023179A Withdrawn JP2013150605A (ja) 1995-03-07 2013-02-08 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP8527061A Withdrawn JPH11507203A (ja) 1995-03-07 1996-03-07 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法
JP2007260391A Withdrawn JP2008099687A (ja) 1995-03-07 2007-10-03 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013023179A Withdrawn JP2013150605A (ja) 1995-03-07 2013-02-08 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法

Country Status (11)

Country Link
US (1) US5869282A (ja)
EP (1) EP0813545B1 (ja)
JP (4) JPH11507203A (ja)
AT (1) ATE442381T1 (ja)
AU (1) AU718955B2 (ja)
CA (1) CA2214830C (ja)
DE (1) DE69638022D1 (ja)
DK (1) DK0813545T3 (ja)
ES (1) ES2333384T3 (ja)
PT (1) PT813545E (ja)
WO (1) WO1996027610A1 (ja)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869282A (en) * 1991-12-11 1999-02-09 Imperial Cancer Research Technology, Ltd. Nucleotide and protein sequences of the serrate gene and methods based thereon
US6004924A (en) 1991-12-11 1999-12-21 Imperial Cancer Research Technology, Ltd. Protein sequences of serrate gene products
US20050112121A1 (en) * 1992-04-30 2005-05-26 Yale University Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
ATE442373T1 (de) * 1995-06-28 2009-09-15 Imp Cancer Res Tech Nukleotid- und proteinsequenzen von delta-genen von vertebraten und darauf basierende methoden
US5780300A (en) * 1995-09-29 1998-07-14 Yale University Manipulation of non-terminally differentiated cells using the notch pathway
US20050158859A1 (en) * 1995-09-29 2005-07-21 Yale University Manipulation of non-terminally differentiated cells using the Notch pathway
WO1997019172A1 (fr) * 1995-11-17 1997-05-29 Asahi Kasei Kogyo Kabushiki Kaisha Polypeptide suppresseur et de differenciation
WO1998002458A1 (fr) 1996-07-16 1998-01-22 Asahi Kasei Kogyo Kabushiki Kaisha Inhibiteur de differenciation
AU773479B2 (en) * 1996-11-07 2004-05-27 Lorantis Limited Notch
US6887475B1 (en) 1996-11-07 2005-05-03 Lorantis Limited Notch
RO120850B1 (ro) * 1996-11-07 2006-08-30 Imperial College Of Science Technology & Medic "notch"
ES2284205T3 (es) 1997-05-14 2007-11-01 Asahi Kasei Kabushiki Kaisha Nuevo inhibidor de diferenciacion.
US6136952A (en) * 1997-06-25 2000-10-24 University Of Washington Human jagged polypeptide, encoding nucleic acids and methods of use
US6436650B1 (en) 1997-07-23 2002-08-20 Yale University Activated forms of notch and methods based thereon
US6692919B1 (en) * 1997-07-23 2004-02-17 Yale University Activated forms of notch and methods based thereon
WO2000025809A1 (en) * 1998-10-30 2000-05-11 Smith & Nephew Plc Compositions comprising notch receptor manipulating agents
US8084258B2 (en) * 1999-07-12 2011-12-27 University Of Basel Manipulation of tissue of organ type using the notch pathway
GB9927328D0 (en) 1999-11-18 2000-01-12 Lorantis Ltd Immunotherapy
US8044259B2 (en) * 2000-08-03 2011-10-25 The Regents Of The University Of Michigan Determining the capability of a test compound to affect solid tumor stem cells
US6984522B2 (en) * 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
US20020151487A1 (en) * 2000-08-31 2002-10-17 Loyola University Chicago Method and reagents for epithelial barrier formation and treatment of malignant and benign skin disorders by modulating the notch pathway
ES2307568T3 (es) * 2000-12-08 2008-12-01 Coley Pharmaceutical Gmbh Acidos nucleicos de tipo cpg y metodos de uso de los mismos.
GB0118155D0 (en) 2001-07-25 2001-09-19 Lorantis Ltd Superantigen
EP1410018A1 (en) * 2001-07-25 2004-04-21 Lorantis Limited Method for detecting modultators of notch signalling
CA2469204A1 (en) * 2001-12-07 2003-06-19 Regents Of The University Of Michigan Prospective identification and characterization of breast cancer stem cells
US20030185829A1 (en) * 2002-03-12 2003-10-02 Erich Koller Jagged 2 inhibitors for inducing apoptosis
US20040102401A1 (en) * 2002-11-22 2004-05-27 Isis Pharmaceuticals Inc. Modulation of jagged 1 expression
GB0300428D0 (en) * 2003-01-09 2003-02-05 Lorantis Ltd Medical treatment
GB0307472D0 (en) * 2003-04-01 2003-05-07 Lorantis Ltd Medical treatment
EP1639090A4 (en) * 2003-06-09 2008-04-16 Univ Michigan COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER
AU2005209909B8 (en) * 2004-02-03 2009-01-15 The Regents Of The University Of Michigan Compositions and methods for characterizing, regulating, diagnosing, and treating cancer
US20060252073A1 (en) * 2005-04-18 2006-11-09 Regents Of The University Of Michigan Compositions and methods for the treatment of cancer
US20070099209A1 (en) * 2005-06-13 2007-05-03 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
WO2006138275A2 (en) * 2005-06-13 2006-12-28 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
US7723477B2 (en) 2005-10-31 2010-05-25 Oncomed Pharmaceuticals, Inc. Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
AU2006308847C1 (en) * 2005-10-31 2012-05-10 Oncomed Pharmaceuticals, Inc. Compositions and methods for treating and diagnosing cancer
EP1961065A4 (en) 2005-10-31 2009-11-11 Oncomed Pharm Inc COMPOSITIONS AND METHOD FOR DIAGNOSIS AND TREATMENT OF CANCER
WO2008121102A2 (en) * 2006-02-21 2008-10-09 The Regents Of The University Of Michigan Hedgehog signaling pathway antagonist cancer treatment
US8148147B2 (en) * 2007-01-24 2012-04-03 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing pancreatic cancer
WO2008140826A1 (en) * 2007-05-15 2008-11-20 Oncomed Pharmaceuticals, Inc. Compositions and methods for diagnosing and treating cancer
BRPI0919473A2 (pt) 2008-09-26 2017-08-29 Oncomed Pharm Inc Agentes de ligação frizzled e usos dos mesmos
WO2011063237A2 (en) 2009-11-19 2011-05-26 Oncomed Pharmaceuticals, Inc. Jagged-binding agents and uses thereof
TWI535445B (zh) 2010-01-12 2016-06-01 安可美德藥物股份有限公司 Wnt拮抗劑及治療和篩選方法
NZ602700A (en) 2010-04-01 2014-10-31 Oncomed Pharm Inc Frizzled-binding agents and uses thereof
US20130095079A1 (en) 2010-04-09 2013-04-18 Fred Hutchinson Cancer Research Center Compositions and methods for providing hematopoietic function without hla matching
CA3090548A1 (en) 2010-04-09 2011-10-13 Fred Hutchinson Cancer Research Center Compositions and methods for providing hematopoietic function
CA2858069C (en) 2011-12-08 2020-02-11 Fred Hutchinson Cancer Research Center Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells
BR112014031689A2 (pt) 2012-06-22 2017-07-25 Cytomx Therapeutics Inc anticorpos reativos cruzados anti-jagged 1/jagged 2, anticorpos anti-jagged ativáveis e métodos de uso deles
CA2887711A1 (en) 2012-10-23 2014-05-01 Oncomed Pharmaceuticals, Inc. Methods of treating neuroendocrine tumors using wnt pathway-binding agents
AU2014205662B2 (en) 2013-01-08 2019-09-05 Fred Hutchinson Cancer Research Center Compositions and methods for expansion of embryonic hematopoietic stem cells
AU2014212081A1 (en) 2013-02-04 2015-08-13 Oncomed Pharmaceuticals, Inc. Methods and monitoring of treatment with a Wnt pathway inhibitor
US9168300B2 (en) 2013-03-14 2015-10-27 Oncomed Pharmaceuticals, Inc. MET-binding agents and uses thereof
US20160250258A1 (en) 2013-10-31 2016-09-01 Fred Hutchinson Cancer Research Center Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof
EP3247808B1 (en) 2015-01-21 2021-05-05 Fred Hutchinson Cancer Research Center Point-of-care and/or portable platform for gene therapy
US11827904B2 (en) 2015-04-29 2023-11-28 Fred Hutchinson Cancer Center Modified stem cells and uses thereof
US20180355318A1 (en) 2015-04-29 2018-12-13 Fred Hutchinson Cancer Research Center Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof
WO2017096347A1 (en) 2015-12-04 2017-06-08 Fred Hutchinson Cancer Research Center Uses of expanded populations of hematopoietic stem/progenitor cells
US11617745B2 (en) 2018-08-17 2023-04-04 Frequency Therapeutics, Inc. Compositions and methods for generating hair cells by downregulating FOXO
WO2020037323A1 (en) * 2018-08-17 2020-02-20 Frequency Therapeutics, Inc. Compositions and methods for generating hair cells by upregulating jag-1
CN112680471B (zh) * 2019-10-17 2023-08-01 华南农业大学 ZmSPL基因在调控玉米柱头乳突细胞发育中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4889818A (en) 1986-08-22 1989-12-26 Cetus Corporation Purified thermostable enzyme
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5116742A (en) 1986-12-03 1992-05-26 University Patents, Inc. RNA ribozyme restriction endoribonucleases and methods
US4795699A (en) 1987-01-14 1989-01-03 President And Fellows Of Harvard College T7 DNA polymerase
US4981784A (en) * 1987-12-02 1991-01-01 The Salk Institute For Biological Studies Retinoic acid receptor method
IL101728A (en) * 1991-05-03 2007-08-19 Univ Yale Human Abandonment and Delta, Restrictive Areas of Effect in Tophoric Proteins, and Methods Based on Them
US5869282A (en) * 1991-12-11 1999-02-09 Imperial Cancer Research Technology, Ltd. Nucleotide and protein sequences of the serrate gene and methods based thereon
WO1993012141A1 (en) * 1991-12-11 1993-06-24 Yale University Nucleotide and protein sequences of the serrate gene and methods based thereon
US5786158A (en) * 1992-04-30 1998-07-28 Yale University Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
WO1997019172A1 (fr) * 1995-11-17 1997-05-29 Asahi Kasei Kogyo Kabushiki Kaisha Polypeptide suppresseur et de differenciation
JP2000512134A (ja) * 1996-05-31 2000-09-19 ザ ナショナル アメリカン レッド クロス Jagged/Notchタンパク質および核酸に基づく治療および診断の方法および組成物
AU8003400A (en) * 1999-10-06 2001-05-10 Ansgar H. Santel Mitofusins, fzo homologs and functional derivatives thereof
JP5890756B2 (ja) 2012-06-28 2016-03-22 昭和電工株式会社 磁気記録媒体及び磁気記憶装置

Similar Documents

Publication Publication Date Title
JP2010273685A5 (ja)
JP2017513479A5 (ja)
JP2005120106A5 (ja)
JP2012095652A5 (ja)
JP2012522501A5 (ja)
JP2008538183A5 (ja)
JP2016502512A5 (ja)
JP2009148257A5 (ja)
JP2013509879A5 (ja)
JP2014506790A5 (ja)
JP2013502226A5 (ja)
JP2012000112A5 (ja)
JP2007530435A5 (ja)
JP2007175057A5 (ja)
JP2013530689A5 (ja)
NZ600348A (en) Anti-c5a binding moieties with high blocking activity
JP2014514921A5 (ja)
JP2013063981A5 (ja)
JP2012503478A5 (ja)
JP2013523179A5 (ja)
JP2010539926A5 (ja)
UA110599C2 (uk) Пептид для імунотерапії пухлин, включаючи нейрональні пухлини та пухлини мозку
JP2012519489A5 (ja)
JP2009527226A5 (ja)
JP2009136300A5 (ja)